These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27499953)

  • 1. Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.
    Wang X; Zhi X; Zhang Y; An G; Feng G
    J Thorac Dis; 2016 Jul; 8(7):1645-52. PubMed ID: 27499953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China.
    Yang Y; Chen K; Zhou Y; Hu Z; Chen S; Huang Y
    Onco Targets Ther; 2018; 11():587-597. PubMed ID: 29430184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
    PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
    Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
    BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer.
    Zhou C; Chen Z; Dong J; Li J; Shi X; Sun N; Luo M; Zhou F; Tan F; He J
    Cancer Lett; 2015 Oct; 367(2):138-46. PubMed ID: 26213369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer.
    Zhang H; Mao F; Shen T; Luo Q; Ding Z; Qian L; Huang J
    Oncol Lett; 2017 Feb; 13(2):669-676. PubMed ID: 28356944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer.
    Wang N; Guo W; Song X; Liu L; Niu L; Song X; Xie L
    Clin Chem Lab Med; 2020 Aug; 58(9):1535-1545. PubMed ID: 32271158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Jiang HG; Dai CH; Xu YP; Jiang Q; Xia XB; Shu Y; Li J
    Oncol Lett; 2021 Nov; 22(5):792. PubMed ID: 34630703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Application of Plasma miR-34b-3p and miR-302a-5p in the Diagnosis of Non-small Cell Lung Cancer].
    Song Z; Zhang Z; Liu Y
    Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):216-222. PubMed ID: 31014439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.
    Bao M; Pan S; Yang W; Chen S; Shan Y; Shi H
    Int J Clin Exp Pathol; 2018; 11(2):773-780. PubMed ID: 31938164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ; Zheng YH; Wang P; Zhang JZ
    Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA array (miR-182, 200b and 205) for the early diagnosis and poor prognosis predictor of non-small cell lung cancer.
    Zou JG; Ma LF; Li X; Xu FL; Fei XZ; Liu Q; Bai QL; Dong YL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1108-1115. PubMed ID: 30779079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
    Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.